Gavin Wood, Chief Financial Officer at Adaptimmune Therapeutics PLC (ADAP), sold 96,000 shares at $0.01 ($960) on 2025-09-02, disclosed to the SEC on 2025-09-03.
Open-market sale of $960 ADAP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADAP | BUY | 2020-06-30 | $53K | — | Filing → |
| AFFX | SELL | 2015-02-18 | $15K | — | Filing → |
| AFFX | SELL | 2015-01-21 | $265K | — | Filing → |